We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Innovative New Instrument Could Transform Oral Cancer Diagnosis

By HospiMedica International staff writers
Posted on 21 Feb 2023

Identifying lesions of the mouth (dysplasia) that have the potential to become cancerous can be a difficult task and, as a result, patients may receive unnecessary treatments or have missed cancer diagnoses. Currently, dysplasia is diagnosed by examining tissue samples from patients under a microscope. This process is both time-consuming and can be subject to human error, making it unreliable. Now, an innovative new instrument currently under development could transform oral cancer diagnosis.

A research team from the University of Liverpool (Liverpool, UK) and Liverpool Head & Neck Centre (LHNC; Liverpool, UK) is developing the Liverpool Diagnostic Infrared (LDIR) Wand, a hand-held device that can rapidly and accurately identify lesions in the mouth that will develop into cancer. The LDIR wand uses a small number of infrared lasers, combined with machine learning algorithm analysis of infrared spectral images of tissue, to identify the lesions in the mouth that are not currently malignant but will become malignant in the future. The researchers will initially develop a prototype of the LDIR Wand for use in histopathology laboratories that could eventually be used in clinics for real-time diagnostics.


Image: A hand-held device can rapidly and accurately identify lesions in the mouth that will develop into cancer (Photo courtesy of University of Liverpool)
Image: A hand-held device can rapidly and accurately identify lesions in the mouth that will develop into cancer (Photo courtesy of University of Liverpool)

“This instrument addresses a difficult clinical problem in head and neck cancer diagnosis,” said Professor Richard Shaw from the LHNC. “We know that earlier diagnosis is key to saving lives, but predicting cancer risk in oral patches is problematic. For some patients we miss a high risk of cancer developing, but for other patients we cannot safely reassure them without better information”

Related Links:
University of Liverpool
LHNC


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+
New
Mini C-arm Imaging System
Fluoroscan InSight FD

Latest Critical Care News

Ablation Treatment Better Than Medication for Heart Attack Survivors

Cranial Accelerometry Headset Enables Timely and Accurate Prehospital Detection of LVO Strokes

Ingestible Capsule Pump Drugs Directly into Walls of GI Tract